Cancer Drugs
Imfinzi
Also known as: Durvalumab, Anti-PD-L1
Definition
Durvalumab, a PD-L1 inhibitor used as consolidation therapy after chemoradiation for stage III unresectable NSCLC and in other cancer types.
Detailed Explanation
Imfinzi has a unique role in lung cancer as maintenance therapy after chemoradiation, dramatically improving survival. It's also approved for extensive-stage small cell lung cancer in combination with chemotherapy and for biliary tract cancers.